Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
He F, Wu Z, Liu C, Zhu Y, Zhou Y, Tian E, Rosin-Arbesfeld R, Yang D, Wang MW, Zhu D. Signal Transduct Target Ther. 2024 May 29; 9(1):139. Epub 2024 May 29.